Seroresponses and safety of 13 ‐valent pneumococcal conjugate vaccination in kidney transplant recipients

ConclusionA single dose of 13‐valent conjugate pneumococcal vaccine elicits increased titres and breadth of functional anti‐pneumococcal antibodies in kidney transplant recipients without stimulating rejection or donor specific antibodies.This article is protected by copyright. All rights reserved.

Source: Transplant Infectious Disease - March 7, 2018 Category: Transplant Surgery Authors: Claire Dendle, Rhonda L. Stuart, Kevan R. Polkinghorne, Anne Balloch, John Kanellis, Johnathan Ling, Megan Kummrow, Chelsea Moore, Karin Thursky, Jim Buttery, Kim Mulholland, Poh ‐Yi Gan, Stephen Holdsworth, William R. Mulley Tags: Original Report Source Type: research